[Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002118:Calcium / Q000037:antagonists & inhibitors*; D003864:Depression, Chemical; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium; D009570:Nitriles / Q000494:pharmacology*; D010210:Papillary Muscles; D011299:Prenylamine / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil; D011299:Prenylamine; D002118:Calcium
Selektive Hemmung der Myokard-Contractilität durch kompetitive Ca-Antagonisten (Iproveratril, D 600, Prenylamin)